Abstract
Oxidation of retinol to retinaldehyde is an important first step in the biosynthesis of a biologically active retinoic acid, which serves as an activating ligand for retinoic acid receptors. Retinol can be oxidized by a variety of different oxidoreductases found in both the cytosolic and the microsomal fractions of the cells. In the cytosol, the best characterized retinol-active dehydrogenases are the dimeric 40 kDa-subunit zinc metalloenzymes that belong to the superfamily of medium-chain alcohol dehydrogenases. Microsomes contain retinol-active dehydrogenases with 35 kDa-subunit molecular weight that belong to the short-chain dehydrogenase / reductase superfamily. Both types of enzymes recognize other physiological substrates besides retinol and exist in multiple isozymic forms. Isozymes exhibit different tissue distribution and have various catalytic efficiencies for oxidation of retinol. The relative physiological importance of the multiple forms of retinol dehydrogenases is currently being debated. This review summarizes some of our data on the identification and characterization of the candidate cytosolic and m icrosomal retinol dehydrogenases.
Keywords: Dehydrogenases, alcohol dehydrogenase, hydroxysteroid, cellular retinol-binding protein
Current Organic Chemistry
Title: Multifunctional Nature of Human Retinol Dehydrogenases
Volume: 6 Issue: 14
Author(s): N. Y. Kedishvili
Affiliation:
Keywords: Dehydrogenases, alcohol dehydrogenase, hydroxysteroid, cellular retinol-binding protein
Abstract: Oxidation of retinol to retinaldehyde is an important first step in the biosynthesis of a biologically active retinoic acid, which serves as an activating ligand for retinoic acid receptors. Retinol can be oxidized by a variety of different oxidoreductases found in both the cytosolic and the microsomal fractions of the cells. In the cytosol, the best characterized retinol-active dehydrogenases are the dimeric 40 kDa-subunit zinc metalloenzymes that belong to the superfamily of medium-chain alcohol dehydrogenases. Microsomes contain retinol-active dehydrogenases with 35 kDa-subunit molecular weight that belong to the short-chain dehydrogenase / reductase superfamily. Both types of enzymes recognize other physiological substrates besides retinol and exist in multiple isozymic forms. Isozymes exhibit different tissue distribution and have various catalytic efficiencies for oxidation of retinol. The relative physiological importance of the multiple forms of retinol dehydrogenases is currently being debated. This review summarizes some of our data on the identification and characterization of the candidate cytosolic and m icrosomal retinol dehydrogenases.
Export Options
About this article
Cite this article as:
Kedishvili Y. N., Multifunctional Nature of Human Retinol Dehydrogenases, Current Organic Chemistry 2002; 6 (14) . https://dx.doi.org/10.2174/1385272023373400
DOI https://dx.doi.org/10.2174/1385272023373400 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protease Inhibitors in the Clinic
Medicinal Chemistry New Electrocardiographic Features in Brugada Syndrome
Current Cardiology Reviews Proteomic Approaches to Study the Pig Intestinal System
Current Protein & Peptide Science Antioxidant Therapy in Alzheimers Disease: Theory and Practice
Mini-Reviews in Medicinal Chemistry Molecules from Nature: Modulating the Expression of Estrogen Receptor Genes in Breast Cancer Cells
Current Bioactive Compounds NAD Biosynthesis in Humans - Enzymes, Metabolites and Therapeutic Aspects
Current Topics in Medicinal Chemistry Virally Encoded G Protein-Coupled Receptors: Targets for Potentially Innovative Anti-Viral Drug Development
Current Drug Targets Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control
Current Cancer Therapy Reviews Theoretical and Evidence-Based Benefit of Afterload Reduction in the Postoperative Pediatric Heart
Current Vascular Pharmacology Salmonella as Live Trojan Horse for Vaccine Development and Cancer Gene Therapy
Current Gene Therapy ABT-450: A Novel Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Current Medicinal Chemistry TLR3 and TLR4 But not TLR2 are Involved in Vogt-Koyanagi- Harada Disease by Triggering Proinflammatory Cytokines Production Through Promoting the Production of Mitochondrial Reactive Oxygen Species
Current Molecular Medicine A Divide-and-Conquer Strategy for the Prediction of Protein Contact Map
Letters in Drug Design & Discovery B-Mode Ultrasound Study of Carotid Plaques in HIV-Positive Patients to Detect the Presence of Inflammatory Endothelial Lesions
Current HIV Research The Cholesterol Transport Inhibitor U18666a Regulates Amyloid Precursor Protein Metabolism and Trafficking in N2aAPP “Swedish” Cells
Current Alzheimer Research Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets Prediction of Citrullination Sites on the Basis of mRMR Method and SNN
Combinatorial Chemistry & High Throughput Screening Therapeutic Implications of Beta-Adrenergic Receptor Pharmacodynamic Properties
Current Clinical Pharmacology New Strategies in Treatment of Mineral and Bone Disorders and Associated Cardiovascular Disease in Patients with Chronic Kidney Disease
Recent Patents on Cardiovascular Drug Discovery Optimal Medical Therapy for Coronary Artery Disease in 2011 – Perspectives from the STICH Trial
Cardiovascular & Hematological Agents in Medicinal Chemistry